EcoDrugPlus

Tissue Factor-Like

Ensembl ID : ENSSTUG00000014909
Gene Symbol: LOC115195346
3 Cross references
191 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSSTUG00000013774
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSSTUG00000008367
Gene Symbol: TLR8
3 Cross references
173 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSSTUG00000013770
Gene Symbol: TLR8
3 Cross references
174 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSSTUG00000004738
Gene Symbol: TLR8
1 Cross references
130 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSSTUG00000043886
Gene Symbol: TLR8
1 Cross references
130 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSSTUG00000004703
Gene Symbol: LOC115198035
2 Cross references
213 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSTUG00000032345
Gene Symbol: TAAR1
1 Cross references
145 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSSTUG00000032397
Gene Symbol: LOC115174367
3 Cross references
145 Possible Orthologues:

Transcription Factor P65-Like

Ensembl ID : ENSSTUG00000047129
Gene Symbol: LOC115194158
3 Cross references
147 Possible Orthologues:

Transcription Factor P65-Like

Ensembl ID : ENSSTUG00000047072
Gene Symbol: LOC115194156
3 Cross references
172 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1-Like

Ensembl ID : ENSSTUG00000020928
Gene Symbol: LOC115149106
3 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).